More evidence needed for ADP-antagonists to prevent CVD

More evidence needed for ADP-antagonists to prevent CVD in type 2 diabetes

These drugs have been shown to reduce the risk of cardiovascular outcomes in non-diabetic patients.  However, few studies have looked at the diabetic population.  As people with type 2 diabetes are at a substantially increased risk of CVD, we might expect ADP receptor antagonists to offer some benefit. Clinical question In patients with type 2 …

More evidence needed for ADP-antagonists to prevent CVD in type 2 diabetes Read More »